How about Jilin Angel Pharmaceutical Co., Ltd.?

Introduction: The company was established in May, 1998. It is a high-tech joint-stock enterprise integrating scientific research, development, production, sales and breeding of medicinal animals and plants. The company is mainly engaged in the research, development, production, sales and cultivation of Chinese herbal medicines, with Chinese herbal medicines for treating cardiovascular and cerebrovascular diseases, digestive system diseases and bone injuries as the leading varieties. The main products are Huoxue Tongmai Tablets, Musk Jiegu Capsules, Xingnao Zaizao Capsules and Simiao Pills. Among them, Simiao Pill is the exclusive product of our company; Simiao Pill, Xingnao Zaizao Capsule, Huoxue Tongmai Tablet, etc. It is a national second-class protected variety of traditional Chinese medicine. At present, the dosage forms produced by the company are tablets, capsules, granules, oral liquid and so on. All dosage forms have obtained GMP certification in the production workshop. The company, formerly known as Tonghua Zijin Pharmaceutical Co., Ltd., was jointly established by Dunhua Kangping Health Food Co., Ltd. and Dunhua Ji Tai Economic & Trade Co., Ltd. on May 25th, 2008.1998165438+1October. According to the resolution of capital increase and share expansion adopted by the company's extraordinary shareholders' meeting, Liuhe Shenfei Helian Industry & Trade Co., Ltd. and Jilin Xiaofeng were added. After the capital increase and share expansion, the registered capital of the company is RMB 30 million. On February 9, 20001year, with the approval of Jilin Provincial People's Government [2006 5438+0] No.5 "Reply on Changing Tonghua Zijin Pharmaceutical Co., Ltd. into Tonghua Zijin Pharmaceutical Co., Ltd. according to law", Tonghua Zijin Pharmaceutical Co., Ltd. took it as June 2000165438+1October 30. On May 28th of the same year, the name of the company was changed to Jilin Angel Pharmaceutical Co., Ltd..1April 2002. With the approval of Jilin Provincial People's GovernmentNo. [2002] 12 "Reply on Approving the Capital Increase and Share Expansion of Jilin Angel Pharmaceutical Co., Ltd.", based on the total share capital of 35 1 at the end of 2006, each/kloc. According to the resolution of the Second Extraordinary General Meeting of Shareholders on September 25th, 2006 and the revised Articles of Association, the Company applied for public offering of RMB ordinary shares (A shares) to increase the registered capital by 65,438+06,900,000.00 yuan. 65438 was approved by China Securities Regulatory Commission (Jian Zheng Fa Zi (2007) No.25) on October 29th, 2007, and it was agreed that the company would publicly issue16,900,000 RMB ordinary shares (A shares), with a par value of 1.00 RMB per share and an issue price of 9.00 RMB per share. The company issued 65,438+06,900,000 shares of RMB common stock (A shares) to the public by combining off-line allotment to the inquiry object and online pricing issue to the public investors, and listed on Shenzhen Stock Exchange on March 2, 2007.

Legal Representative: Guo Chunlin.

Established: 1998-05-25

Registered capital: 65,438 yuan+0,280,759,826 yuan.

Industrial and commercial registration number: 22000000052632

Type of enterprise: joint stock limited company (listing, natural person investment or holding)

Company Address: No.88 Yingli Road, Liuhe County, Jilin Province